Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
703.06
505.04
463.54
461.33
357.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
703.06
505.04
463.54
461.33
357.09
Raw Material Cost
39.06
8.93
6.31
0.32
0.00
Purchase of Finished goods
652.13
485.18
424.04
457.25
358.01
(Increase) / Decrease In Stocks
-71.81
-54.35
-7.87
-26.62
-22.91
Employee Cost
7.44
4.84
3.64
2.98
2.43
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
24.92
21.40
14.61
12.71
8.63
Total Expenditure (Excl Depreciation)
651.74
466.00
440.73
446.64
346.17
Operating Profit (PBDIT) excl Other Income
51.32
39.04
22.81
14.69
10.92
Other Income
8.71
2.66
2.61
1.12
0.46
Operating Profit (PBDIT)
60.03
41.70
25.42
15.81
11.38
Interest
25.70
16.04
8.94
5.40
3.38
Exceptional Items
0.00
-2.82
0.00
0.00
0.00
Gross Profit (PBDT)
34.33
22.84
16.48
10.41
8.00
Depreciation
3.79
2.81
1.24
0.91
0.87
Profit Before Tax
30.54
20.02
15.23
9.50
7.14
Tax
7.17
5.05
3.77
2.46
1.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.37
14.97
11.46
7.04
5.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
23.37
14.97
11.46
7.04
5.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.07
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.30
14.97
11.46
7.04
5.25
Equity Capital
24.07
24.07
24.07
24.07
9.75
Face Value
1.0
1.0
10.0
10.0
10.0
Reserves
131.03
103.59
87.64
76.91
20.03
Earnings per share (EPS)
0.97
0.62
0.48
2.92
5.38
Diluted Earnings per share
0.97
0.62
0.48
5.48
5.46
Operating Profit Margin (Excl OI)
7.3%
7.73%
4.92%
3.18%
3.06%
Gross Profit Margin
4.88%
4.52%
3.56%
2.26%
2.24%
PAT Margin
3.32%
2.96%
2.47%
1.53%
1.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 39.21% vs 8.95% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 55.64% vs 30.63% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 31.45% vs 71.15% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 60.22% vs 79.42% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Sudarshan Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
703.06
0
703.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
703.06
0
703.06
Raw Material Cost
39.06
0
39.06
Purchase of Finished goods
652.13
0
652.13
(Increase) / Decrease In Stocks
-71.81
0
-71.81
Employee Cost
7.44
0
7.44
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
24.92
0.00
24.92
Total Expenditure (Excl Depreciation)
651.74
0
651.74
Operating Profit (PBDIT) excl Other Income
51.32
0.00
51.32
Other Income
8.71
0
8.71
Operating Profit (PBDIT)
60.03
0
60.03
Interest
25.70
0
25.70
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
34.33
0
34.33
Depreciation
3.79
0
3.79
Profit Before Tax
30.54
0
30.54
Tax
7.17
0
7.17
Provisions and contingencies
0.00
0
0.00
Profit After Tax
23.37
0
23.37
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
23.37
0
23.37
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.07
0
-0.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.30
0
23.30
Equity Capital
24.07
0
24.07
Face Value
1.00
0
0.00
Reserves
131.03
0
131.03
Earnings per share (EPS)
0.97
0
0.97
Diluted Earnings per share
0.97
0
0.97
Operating Profit Margin (Excl OI)
7.30%
0%
0.00
7.30%
Gross Profit Margin
4.88%
0%
0.00
4.88%
PAT Margin
3.32%
0%
0.00
3.32%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 703.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 39.21% vs 8.95% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 23.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 55.64% vs 30.63% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.45% vs 71.15% in Mar 2025
Annual - Interest
Interest 25.70 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 60.22% vs 79.42% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.30%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
